You have 9 free searches left this month | for more free features.

Immune Dysregulation

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

X-linked Severe Combined Immunodeficiency Trial in London (Single infusion of autologous CD34+ cells transduced with the

Unknown status
  • X-linked Severe Combined Immunodeficiency
  • Single infusion of autologous CD34+ cells transduced with the self-inactivating (SIN) gammaretroviral vector pSRS11.EFS.IL2RG.pre
  • London, United Kingdom
    Great Ormond Street Hospital for Children NHS Trust
Jul 31, 2017

Multiple Sclerosis Trial in Tehran (intravenous injection of mesenchymal stem cells, injection of cell free media)

Completed
  • Multiple Sclerosis
  • intravenous injection of mesenchymal stem cells
  • injection of cell free media
  • Tehran, Iran, Islamic Republic of
    Royan Institute
Mar 6, 2018

AMP-514 in Blood Samples From Solid Tumors Undergoing

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 5, 2017

Prostate Cancer Trial in United States (PROSTVAC®-VF/TRICOM™)

Completed
  • Prostate Cancer
  • PROSTVAC®-VF/TRICOM™
  • Homewood, Alabama
  • +46 more
Sep 7, 2017

Nicotine Addiction, Cigarette Smoking Trial in Stony Brook (Nicotine, MR Compatible Nicotine Delivery Device)

Unknown status
  • Nicotine Addiction
  • Cigarette Smoking
  • Nicotine
  • MR Compatible Nicotine Delivery Device
  • Stony Brook, New York
    Bioengineering Building , Stony Brook University
Jun 29, 2017

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Stage IA Breast Cancer Trial in Seattle (drug,

Completed
  • Estrogen Receptor-positive Breast Cancer
  • +8 more
  • doxorubicin hydrochloride
  • +6 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Aug 30, 2017

Behaviour Trial in Oxford (Bimuno (BGOS), Maltodextrin)

Unknown status
  • Behaviour
  • Bimuno (BGOS)
  • Maltodextrin
  • Oxford, Oxfordshire, United Kingdom
    Oxford University Department of Psychiatry
Mar 14, 2018

Chronic Lymphocytic Leukemia, GVHD, Hodgkin's Disease Trial run by the NCI (Th2 cells in allo HSCTT, Th2 Cells)

Completed
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Th2 cells in allo HSCTT
  • Th2 Cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018

Steroid Replacement Therapy in Septic Shock

Unknown status
  • Septic Shock
  • Aldosterone / renin dosage
  • Natriuresis
  • Dijon, France
    Chu Dijon Bourgogne
Aug 21, 2017

Dietary Modification Trial (GOS, B-GOS 3%, B-GOS 2%)

Completed
  • Dietary Modification
  • GOS
  • +3 more
  • (no location specified)
Jul 17, 2017

Motion Immune Magnetic Resonance Imaging (MRI)

Completed
  • Parkinson's Disease
  • Multiplex Sensitivity Encoding (MUSE)
  • Durham, North Carolina
    Duke University Medical Center
Aug 10, 2017

Alzheimer's Disease Trial in Portland (Lipoic acid and fish oil concentrate, Placebo)

Completed
  • Alzheimer's Disease
  • Lipoic acid and fish oil concentrate
  • Placebo
  • Portland, Oregon
    Oregon Health & Science University
Mar 1, 2017

Glioblastoma Platelet Activation Study

Completed
  • Glioblastoma
  • Circulating Platelet-monocyte Conjugates
    • Greifswald, Germany
      Department of Neurosurgery
    Jul 31, 2017

    Lymphocyte Counts in Immune Thrombocytopenic Purpura

    Unknown status
    • Thrombocytopenic Purpura
    • complete blood picture
    • (no location specified)
    Aug 7, 2017

    Primary Immune Deficiency Disorder Trial in Caen (Internal Medicine consultation)

    Unknown status
    • Primary Immune Deficiency Disorder
    • Internal Medicine consultation
    • Caen, France
      Caen University Hospital
    Aug 16, 2017

    Ataxia Telangiectasia Trial in Frankfurt (bioelectrical impedance analysis, blood draw, transient elastography (FibroScan))

    Unknown status
    • Ataxia Telangiectasia
    • bioelectrical impedance analysis
    • +4 more
    • Frankfurt, Hessen, Germany
      Children's Hospital, Allergology, Pneumology and Cystic Fibrosis
    Nov 29, 2017

    Recurrent Bladder Carcinoma, Stage II Bladder Cancer, Stage III Bladder Cancer Trial in Seattle (Cisplatin, Gemcitabine

    Completed
    • Recurrent Bladder Carcinoma
    • +3 more
    • Seattle, Washington
    • +1 more
    Sep 20, 2017

    Serum miRNA-30a in Childhood Nephrotic Syndrome

    Unknown status
    • Nephrotic Syndrome Steroid-Resistant
    • ‗Urine analysis ‗Urine protein quantification ‗Serum albumin ‗Lipid profile.Quantitation of miRNA -30a by Real-time polymerase chain reaction (Q-PCR) in peripheral blood.
    • (no location specified)
    Aug 1, 2017

    Healthy NIH Employees at Baseline and After Immunization With

    Completed
    • Healthy Volunteers
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Oct 5, 2017

      Immunopathogenesis of Food Allergy and Eosinophilic

      Terminated
      • Eosinophilic Gastroenteritis
      • Eosinophilic Esophagitis
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Oct 5, 2017

        Neurotoxicity Trial in Chandigarh (Anesthetic Agents)

        Completed
        • Neurotoxicity
        • Anesthetic Agents
        • Chandigarh, India
          Postgraduate Institute of Medical Education and Research
        Sep 18, 2017

        Ulcerative Colitis Trial in Rennes (Probiotics in the form of cheese portion)

        Terminated
        • Ulcerative Colitis
        • Probiotics in the form of cheese portion
        • Rennes, France
          CHU de Rennes
        Jul 3, 2017

        Intraocular Melanoma, Malignant Conjunctival Tumor, Melanoma (Skin) Trial in Pittsburgh (Peptide vaccine, GM-CSF, PF3512676)

        Completed
        • Intraocular Melanoma
        • +2 more
        • Peptide vaccine
        • +2 more
        • Pittsburgh, Pennsylvania
          UPMC Cancer Centers
        Jun 21, 2017

        Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Detroit (biological, drug, radiation)

        Completed
        • Chronic Myeloproliferative Disorders
        • +5 more
        • rituximab
        • +9 more
        • Detroit, Michigan
          Barbara Ann Karmanos Cancer Institute
        May 26, 2017

        Cytomegalovirus Infection, Healthy, no Evidence of Disease Trial in Duarte (multi-CMV epitope modified vaccinia Ankara vaccine,

        Completed
        • Cytomegalovirus Infection
        • Healthy, no Evidence of Disease
        • multi-CMV epitope modified vaccinia Ankara vaccine
        • laboratory biomarker analysis
        • Duarte, California
          City of Hope Medical Center
        Jul 31, 2017